Supriya S. Jain

Supriya S. Jain

Auto-generated profile, based on publicly available information

Supriya S. Jain

Department of Pediatrics, Division of Cardiology, New York Medical College-Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Pediatrics
Verified
Journal Article
Closed access
PDF file
SJSupriya S. Jain
Supriya S. Jain
JSJeremy M. Steele
Jeremy M. Steele
BFBrian Fonseca
Brian Fonseca
SHSihong Huang
Sihong Huang
SSSanket Shah
Sanket Shah
LGLars Grosse-Wortmann
Lars Grosse-Wortmann
OBJECTIVES: In this study, we aimed to characterize the clinical presentation, short-term prognosis, and myocardial tissue changes as noted on cardiovascular magnetic resonance (CMR) or cardiac MRI in pediatric patients with coronavirus disease 2019 vaccination-associated myocarditis (C-VAM). METHODS: In this retrospective multicenter study across 16 US hospitals, patients <21 years of age with a diagnosis of C-VAM were included and compared with a cohort with multisystem inflammatory syndrome in children. Younger children with C-VAM were compared with older adolescents. RESULTS: Sixty-three patients with a mean age of 15.6 years were included; 92% were male. All had received a messenger RNA vaccine and, except for one, presented after the second dose. Four patients had significant dysrhythmia; 14% had mild left ventricular dysfunction on echocardiography, which resolved on discharge; 88% met the diagnostic CMR Lake Louise criteria for myocarditis. Myocardial injury as evidenced by late gadolinium enhancement on CMR was more prevalent in comparison with multisystem inflammatory syndrome in children. None of the patients required inotropic, mechanical, or circulatory support. There were no deaths. Follow-up data obtained in 86% of patients at a mean of 35 days revealed resolution of symptoms, arrhythmias, and ventricular dysfunction. CONCLUSIONS: Clinical characteristics and early outcomes are similar between the different pediatric age groups in C-VAM. The hospital course is mild, with quick clinical recovery and excellent short-term outcomes. Myocardial injury and edema are noted on CMR. Close follow-up and further studies are needed to understand the long-term implications and mechanism of these myocardial tissue changes.

6 September 2024 in eClinicalMedicine
Verified
Journal Article
Open access
SJSupriya S. Jain
Supriya S. Jain
SASteven A. Anderson
Steven A. Anderson
JSJeremy M. Steele
Jeremy M. Steele
HWHunter C. Wilson
Hunter C. Wilson
JMJuan Carlos Muniz
Juan Carlos Muniz
LGLars Grosse-Wortmann
Lars Grosse-Wortmann
We aimed to study the clinical characteristics, myocardial injury, and longitudinal outcomes of COVID-19 vaccine-associated myocarditis (C-VAM). In this longitudinal retrospective observational cohort multicenter study across 38 hospitals in the United States, 333 patients with C-VAM were compared with 100 patients with multisystem inflammatory syndrome in children (MIS-C). We included patients ≤30 years of age with a clinical diagnosis of acute myocarditis after COVID-19 vaccination based on clinical presentation, abnormal biomarkers and/or cardiovascular imaging findings. Demographics, past medical history, hospital course, biochemistry results, cardiovascular imaging, and follow-up information from April 2021 to November 2022 were collected. The primary outcome was presence of myocardial injury as evidenced by late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) imaging. Patients with C-VAM were predominantly white (67%) adolescent males (91%, 15.7 ± 2.8 years). Their initial clinical course was more likely to be mild (80% vs. 23%, p < 0.001) and cardiac dysfunction was less common (17% vs. 68%, p < 0.0001), compared to MIS-C. In contrast, LGE on CMR was more prevalent in C-VAM (82% vs. 16%, p < 0.001). The probability of LGE was higher in males (OR 3.28 [95% CI: 0.99, 10.6, p = 0.052]), in older patients (>15 years, OR 2.74 [95% CI: 1.28, 5.83, p = 0.009]) and when C-VAM occurred after the first or second dose as compared to the third dose of mRNA vaccine. Mid-term clinical outcomes of C-VAM at a median follow-up of 178 days (IQR 114-285 days) were reassuring. No cardiac deaths or heart transplantations were reported until the time of submission of this report. LGE persisted in 60% of the patients at follow up. Myocardial injury at initial presentation and its persistence at follow up, despite a mild initial course and favorable mid-term clinical outcome, warrants continued clinical surveillance and long-term studies in affected patients with C-VAM. The U.S. Food and Drug Administration.

7 June 2023 in Canadian Journal of Cardiology
Verified
Journal Article
Closed access
AHAshraf S. Harahsheh
Ashraf S. Harahsheh
SSSamay Shah
Samay Shah
FDFrederic Dallaire
Frederic Dallaire
CMCedric Manlhiot
Cedric Manlhiot
MKMichael Khoury
Michael Khoury
Angela YetmanAngela Yetman
Angela Yetman

6 May 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
SLSimon Lee
Simon Lee
AHAshraf S. Harahsheh
Ashraf S. Harahsheh
GRGeetha Raghuveer
Geetha Raghuveer
MPMichael Portman
Michael Portman
ASArash A. Sabati
Arash A. Sabati
BMBrian W. McCrindle
Brian W. McCrindle
Background: There is significant overlap in clinical features between multisystem inflammatory syndrome in children (MIS‐C) and Kawasaki disease (KD). We sought to compare the prevalence, severity, and associated factors for coronary artery (CA) involvement. Methods and Results: From January 1, 2020 through January 31, 2023, 1191 patients with MIS‐C and 554 patients contemporaneously diagnosed with KD were enrolled into the International Kawasaki Disease Registry. Demographic and clinical features, laboratory values, maximum Z score in any CA branch at any time point, and worst left ventricular ejection fraction, were compared between groups. Factors associated with CA aneurysms (maximum Z score in any CA branch +2.5 or greater) were determined separately for each diagnosis using multivariable logistic regression analyses. The prevalence of CA aneurysms was lower for MIS‐C versus KD (16% versus 25%, respectively; P <0.001) and less severe by size category (1.2% with medium/large CA aneurysm versus 9.6%, respectively). Male sex and lower nadir hemoglobin levels were associated with greater odds of CA aneurysms for both groups. Additional associated factors for KD patients included age<6 months, fewer clinical KD criteria (more incomplete presentation), presentation with shock, and greater total days of fever. There were no additional associated factors for patients with MIS‐C. Using exploratory splines, there was a trend of improvement in Z scores within 30 days of illness for both MIS‐C and KD for CA involvement other than large aneurysms. Conclusions: CA involvement for patients with MIS‐C was less prevalent and milder in severity compared with contemporaneous patients with KD, with fewer associated factors, and a high prevalence of regression to a normal luminal dimension.

7 May 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
DCDevyani Chowdhury
Devyani Chowdhury
NBNeha Bansal
Neha Bansal
AAAnnette Ansong
Annette Ansong
CBCarissa Marrie Baker-Smith
Carissa Marrie Baker-Smith
HBHolly Bauser‐Heaton
Holly Bauser‐Heaton
RWRoberta Williams
Roberta Williams
Evidence from medicine and other fields has shown that gender diversity results in better decision making and outcomes. The incoming workforce of congenital heart specialists (especially in pediatric cardiology) appears to be more gender balanced, but past studies have shown many inequities. Gender‐associated differences in leadership positions, opportunities presented for academic advancement, and recognition for academic contributions to the field persist. In addition, compensation packages remain disparate if evaluated based on gender with equivalent experience and expertise. This review explores these inequities and has suggested individual and institutional changes that could be made to recruit and retain women, monitor the climate of the institution, and identify and eliminate bias in areas like salary and promotions.

30 November 2024 in Canadian Journal of Cardiology
Verified
Journal Article
Open access
SJSupriya S. Jain
Supriya S. Jain
AHAshraf S. Harahsheh
Ashraf S. Harahsheh
SLSimon Lee
Simon Lee
GRGeetha Raghuveer
Geetha Raghuveer
NDNagib Dahdah
Nagib Dahdah
VZVarsha Zadokar
Varsha Zadokar
While clinical overlap between Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) has been evident, information regarding those presenting with shock has been limited. We sought to determine associations with shock within and between diagnosis groups. The International KD Registry enrolled contemporaneous patients with either KD or MIS-C from 39 sites in 7 countries from 01/2020 to 01/2023. Demographics, clinical features and presentation, management, laboratory values, and outcomes were compared between the diagnosis/shock groups. Shock at presentation was noted for 19 of 672 (2.8%) KD patients and 653 of 1472 (44%; p<0.001) MIS-C patients. Within both groups, patients with shock were significantly more likely to be admitted to the intensive care unit, receive inotropes and to have greater laboratory abnormalities indicative of hyperinflammation and organ dysfunction, including abnormal cardiac biomarkers. Patients with KD and shock had a greater maximum coronary artery Z score (median +2.62) versus KD patients without shock (+1.36; p<0.001) and MIS-C patients with shock (+1.45; versus +1.32 for those without shock; p<0.001). They were also more likely to have large coronary artery aneurysms. In contrast, MIS-C patients with shock had lower left ventricular ejection fraction (mean 51.6%) versus MIS-C patients without shock (56.6%; p<0.001) and KD patients with shock (56.7%; versus 62.8% for those without shock; p=0.04). While patients with KD presenting with shock are clinically similar to patients with MIS-C, especially those with shock, they have more severe coronary artery involvement, while MIS-C patients with shock have lower left ventricular ejection fraction.